Morgan Stanley upgraded to a buy: strong dividends, earnings growth, and profit margins outweigh valuation risks. Learn more ...

Immunic (NASDAQ:IMUX – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to ...

Investors and traders were bracing for Wednesday’s consumer-price index report for January to mostly reflect either little ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Meta Platforms notched its 16th straight winning session on Monday, the longest streak among the Magnificent Seven.

Regeneron, which is seeking FDA approval of linvoseltamab for adults with relapsed/refractory multiple myeloma that has progressed after at least three prior therapies, said the agency set a new ...

Our analysts reveal one thing that will move the fantasy football needle this offseason for each AFC squad.

Such may be the case for the following 2 picks, both of which are now trading at or near multi-year lows and offer yields ...

A new study has revealed the top 30 phrases that drive us up the wall when dealing with customer service, with millions of ...

Recent studies suggest a majority of mergers fail. Two tenured professors identified the potential pitfalls and keys to ...

Series that offers listeners the chance to take a long, slow look at great artworks, photographed in incredible detail.